The looming threat of EVALI in India: addressing the rise of vaping: associated lung injury
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20251412Keywords:
EVALI epidemic, Public health crisis, E-cigarettes, VapingAbstract
Vaping is currently banned in India, yet documents reveal a concerning prevalence of vaping across the country. This paradox calls for immediate attention, as the dangers associated with vaping are not hypothetical but have already caused a significant health crisis globally. The EVALI (e-cigarette or vaping-associated lung injury) epidemic in the United States serves as a stark warning. In the U.S., this epidemic overwhelmed healthcare systems, leading to thousands of hospitalizations and even deaths. If such a situation were to occur in India, the consequences would be disastrous. India’s healthcare system, though robust in many aspects, is not prepared to handle an outbreak of vaping-related health crises. With vaping being banned, healthcare workers may lack the necessary training and resources to effectively address the health complications associated with it. The situation could spiral out of control, straining healthcare infrastructure and putting lives at risk. Therefore, it is imperative that stricter enforcement of the vaping ban is implemented, accompanied by heightened awareness campaigns for both healthcare professionals and the general public. Preventive measures, including education on the dangers of vaping and the enforcement of the law, are essential to safeguard public health and prevent a potential public health disaster in India.
Metrics
References
Fadus MC, Smith TT, Squeglia LM. The rise of e-cigarettes, pod mod devices, and JUUL among youth: Factors influencing use, health implications, and downstream effects. Drug Alcohol Depend. 2019;201:85-93. DOI: https://doi.org/10.1016/j.drugalcdep.2019.04.011
Eaton DL. E-cigarette devices, uses, and exposures. In: National Institutes of Health (NIH). 2018.
Pettigrew S, Alvin Santos J, Miller M, Sudhir Raj T, Jun M, Morelli G, Jones A. E-cigarettes: A continuing public health challenge in India despite comprehensive bans. Prev Med Rep. 2023;31:102108. DOI: https://doi.org/10.1016/j.pmedr.2022.102108
Flor LS, Reitsma MB, Gupta V. The effects of tobacco control policies on global smoking prevalence. Nat Med. 2021;27:239-43. DOI: https://doi.org/10.1038/s41591-020-01210-8
Cheng HG, Largo EG, Gogova M. E-cigarette use and onset of first cigarette smoking among adolescents: An empirical test of the 'common liability' theory. F1000Res. 2019;8:2099. DOI: https://doi.org/10.12688/f1000research.21377.1
Grana R, Benowitz N, Glantz SA. E-cigarettes: a scientific review. Circulation. 2014;129(19):1972-86. DOI: https://doi.org/10.1161/CIRCULATIONAHA.114.007667
Chen IL. FDA summary of adverse events on electronic cigarettes. Nicotine Tob Res. 2013;15(2):615-6. DOI: https://doi.org/10.1093/ntr/nts145
Reagan-Steiner S, Gary J, Matkovic E, Ritter JM, Shieh WJ, Martines RB, et al. Lung Injury Response Pathology Working Group. Pathological findings in suspected cases of e-cigarette, or vaping, product use-associated lung injury (EVALI): a case series. Lancet Respir Med. 2020;8(12):1219-32. DOI: https://doi.org/10.1016/S2213-2600(20)30321-0
King BA, Jones CM, Baldwin GT, Briss PA. The EVALI and Youth Vaping Epidemics-Implications for Public Health. N Engl J Med. 2020;382(8):689-91. DOI: https://doi.org/10.1056/NEJMp1916171
Rebuli ME, Rose JJ, Noël A, Croft DP, Benowitz NL, Cohen AH, et al. The E-cigarette or Vaping Product Use-Associated Lung Injury Epidemic: Pathogenesis, Management, and Future Directions: An Official American Thoracic Society Workshop Report. Ann Am Thorac Soc. 2023;20(1):1-17. DOI: https://doi.org/10.1513/AnnalsATS.202209-796ST
Layden JE, Ghinai I, Pray I, Kimball A, Layer M, Tenforde MW, et al. Pulmonary Illness Related to E-Cigarette Use in Illinois and Wisconsin-Final Report. N Engl J Med. 2020;382(10):903-16. DOI: https://doi.org/10.1056/NEJMoa1911614
Werner AK, Koumans EH, Chatham-Stephens K, Salvatore PP, Armatas C, Byers P, et al. Lung Injury Response Mortality Working Group. Hospitalizations and Deaths Associated with EVALI. N Engl J Med. 2020;382(17):1589-98. DOI: https://doi.org/10.1056/NEJMoa1915314
The Lancet Respiratory Medicine. The EVALI outbreak and vaping in the COVID-19 era. Lancet Respir Med. 2020;8(9):831. DOI: https://doi.org/10.1016/S2213-2600(20)30360-X
Blount BC, Karwowski MP, Shields PG, Morel-Espinosa M, Valentin-Blasini L, Gardner M, et al. Lung Injury Response Laboratory Working Group. Vitamin E Acetate in Bronchoalveolar-Lavage Fluid Associated with EVALI. N Eng J Med. 2020;382(8):697-705. DOI: https://doi.org/10.1056/NEJMoa1916433
Lal A, Mishra AK, Sahu KK. Vitamin E Acetate and E-Cigarette or Vaping Product-Associated Lung Injury (EVALI): An Update. Am J Med. 2020;133(5):e204. DOI: https://doi.org/10.1016/j.amjmed.2019.11.005
Zulfiqar H, Sankari A, Rahman O. Vaping-Associated Pulmonary Injury. n: StatPearls. Treasure Island (FL): StatPearls Publishing. 2024.
Chand HS, Muthumalage T, Maziak W, Rahman I. Pulmonary Toxicity and the Pathophysiology of Electronic Cigarette, or Vaping Product, Use Associated Lung Injury. Front Pharmacol. 2020;10:1619. DOI: https://doi.org/10.3389/fphar.2019.01619
Dyer O. India bans e-cigarettes by executive order. BMJ. 2019;366:l5649. DOI: https://doi.org/10.1136/bmj.l5649
Amalia B, Kapoor S, Sharma R, Singh RJ. E-cigarette retailer storefront availability following a nationwide prohibition of e-cigarettes in India: A multicentric compliance assessment. Tob. Prev. Cessat. 2020;6:42. DOI: https://doi.org/10.18332/tpc/123822
Gentzke AS, Wang TW, Cornelius M, Eunice PL, Chunfeng R, Michael DS, et al. Tobacco product use and associated factors among middle and high school students-National Youth Tobacco Survey, United States, 2021. MMWR Surveill Summ. 2022;71(SS-5):1-29. DOI: https://doi.org/10.15585/mmwr.ss7105a1
U. S. Department of Health and Human Services. E-cigarette Use Among Youth and Young Adults: A Report of the Surgeon General. Centers for Disease Control and Prevention. 2016.
Jamal A, Park-Lee, E, Birdsey J, Andrenita W, Monica C, Maria RC, et al. Tobacco product use among middle and high school students-National Youth Tobacco Survey, United States. MMWR Morb Mortal Wkly Rep. 2024;73(41):917-24. DOI: https://doi.org/10.15585/mmwr.mm7341a2
Villanti AC, Johnson AL, Glasser AM, Shyanika WR, Bridget KA, Kevin PC, et al. Association of flavored tobacco use with tobacco initiation and subsequent use among US youth and adults, 2013-2015. JAMA Netw Open. 2019;2(10):e1913804. DOI: https://doi.org/10.1001/jamanetworkopen.2019.13804
Bahl D, Bassi S, Thapliyal N, Aneja K, Sinha P, Arora M. Unveiling the Digital Landscape of E-Cigarette Marketing in India: Evidence from Mixed Method Study. Tob Use Insights. 2024;17:1179173X241264504. DOI: https://doi.org/10.1177/1179173X241264504
Nikhar Y, Khanke V, Kokane N, Khatri S, Datarkar S, Ingole R. Critical analysis of harm reduction tactics and the illusion of safety created by the tobacco industry. J Chem Health Risks. 2024;14(6):1073-7.
Gowda MR, Thangiah S. Does India's ban on electronic cigarettes improve public health outcomes? Indian Public Policy Rev. 2023;4(2):27-54. DOI: https://doi.org/10.55763/ippr.2023.04.02.002
Gupta PC, Pednekar MS, Narake S, Puntambekar N, Mc Carthy WJ, Mistry R. Awareness and Use of e-cigarettes among Adolescents and Their Adult Caregivers in Two Cities of India. Asian Pac J Cancer Prev. 2023;24(7):2195-2197. DOI: https://doi.org/10.31557/APJCP.2023.24.7.2195
Jaswal N, Bhatt G, Goel S. Awareness of electronic cigarettes in India: Findings from the 2016–2017 Global Adult Tobacco Survey (GATS). Tobacco Prevention Cessation. 2023;9(1):3. DOI: https://doi.org/10.18332/tpc/156446
Boudi FB, Patel S, Boudi A, Chan C. Vitamin E Acetate as a Plausible Cause of Acute Vaping-related Illness. Cureus. 2019;11(12):e6350. DOI: https://doi.org/10.7759/cureus.6350